Tristate Regional Liver Transplant Anesthesiology Conference
This SATA regional meeting is to provide the audience the updated knowledge on several critical management issues in abdominal transplant patients.
Transplant anesthesiologists, intensivists, transplant surgeons, residents, and fellows.
On completion of this activity the participants will be able to
1. Compare liver transplantation in India vs the united states
2. Prepare for coagulation and transfusion challenges in liver transplantation
3. Evaluate ex vivo perfusion in liver transplantation.
4. Describe Alcoholic hepatitis and its associated controversies in transplantation.
9:00 - 9:15: Welcome –Gebhard Wagener, MD; Columbia University Irving Medical Center
9:15 - 10:30 Moderator: Christine Lennon, MD; Weill Cornell Medicine
• Hyponatremia in Liver Transplanatation
Gebhard Wagener, MD; Columbia University Irving Medical Center
• Pro/con transplant during COVID
Pro: Parissa Tabrizian, MD; Mount Sinai Medical Center
Con: Gebhard Wagener,MD; Columbia University Irving Medical Center
• Alcoholic hepatitis and transplant controversies
James Park, MD; New York University
10:30 – 11:00: Break
11:00-12:15. Moderator: Kevin Fitzmartin MD; Montefiore Medical Center
• Machine perfusion, updates and perspective
Juan P. Rocca, MD; Montefiore Medical Center
• Cardiac Arrest during liver transplantation
Ted Sakai, MD; University of Pittsburgh Medical Center
• What’s new in coagulation and transfusion management
Nicolette Schlichting, MD; Mount Sinai Medical Center
12:30-1:45: Case discussions: Case based discussion with expert panel
Moderator: Tricia Brentjens MD; Columbia University Irving Medical Center
• Acute liver failure: ICU case presentation
Uyen To MD. Yale School of Medicine
• Porto-pulmonary hypertension: Intraoperative management and outcome
Nikhil Chawla MD. Yale School of Medicine
• Hepatic artery pseudoaneurysm: Case presentation
Shreyajit Kumar M.D. Weill Cornell Medicine
1:45-2:00: Closing Remarks Ranjit Deshpande MD FCCM Yale School of Medicine
Organizing committee members:
• Jeron Zerillo, MD (The Mount Sinai Hospital, New York, NY)
• Gebhard Wagener, MD (Columbia university medical center, New York, NY)
• Marina Moguilevitch, MD (Montefiore Medical Center, Bronx, NY)
• Christine Lennon, MD (Weill Cornell Medicine, New York, NY)
• Joseph Yeh, (NYU Langone, New York, NY)
• Ranjit Deshpande, MD, FCCM (Yale New Haven Hospital, New Haven, CT)
• Tetsuro Sakai, MD, PhD, MHA (University of Pittsburgh Medical Center)
• Akila Rajakumar, MBBS, MD, FRCA; Rela Institute & Medical Centre, Chennai, India
• Gebhard Wagener, MD; Columbia University Irving Medical Center
• James Park, MD; New York University
• Juan P. Rocca, MD; Montefiore Medical Center
• Kevin Fitzmartin MD; Montefiore Medical Center
• Nikhil Chawla, MD; Yale School of Medicine
• Nicole Schlichting, MD; Mount Sinai Medical Center
• Parissa Tabrizian, MD; Mount Sinai Medical Center
• Shreyajit Kumar M.D. Weill Cornell Medicine
• Ted Sakai, MD; University of Pittsburgh Medical Center
• Tricia Brentjens MD; Columbia University Irving Medical Center
• Uyen To MD; Yale School of Medicine
All individuals in a position to control the content of this education activity including members of the planning committee, speakers, presenters, authors, and/or content reviewers have disclosed all relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services, used on, or consumed by, patients.
The following relevant financial relationships were disclosed:
• Tetsuro Sakai, MD, PhD, MHA (Book royalty, Springer Inc.)
• Juan P. Rocca, MD Principal investigator for the OCS™ Liver DCD Trial, using the The Portable Organ Care System (OCS™) Liver and the PILOT Study (Perfusion to Improve Liver Outcomes inTransplantation), using the LifePort Liver Transporter (LLT) system.
No other planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The University of Pittsburgh designates this live activity for a maximum of 4.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other Healthcare Professionals
Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
- 4.25 AMA PRA Category 1 Credit™The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
- 4.25 Attendance
Instructions to Register
This program is free.
Registering online is the quickest and easiest way to reserve your space at CCEHS conferences.
• Visit our online registration site at: https://cce.upmc.com
• Here is the direct link to register: https://cce.upmc.com/tristate-regional-liver-transplant-anesthesiology
• Choose the "All Registrants" registration category then click add to cart. Enter all the requested information. After registering, an electronic confirmation will be sent to you. Online registration is complete upon receipt of a confirmation email. If you do not receive the confirmation email immediately, please contact
Participation of all individuals is encouraged. Advance notifications of any special needs will help us provide better service. Please notify us of your needs at least two weeks in advance of the program by emailing .